Simplex Trading, LLC Reata Pharmaceuticals Inc Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$79.22 - $105.37 $486,648 - $647,287	6,143 Added 52.32%	17,884 $1.82 Million
Q1 2023 Apr 27, 2023	SELL	$30.85 - $93.17 $123,677 - $373,518	-4,009 Reduced 25.45%	11,741 $1.07 Million
Q4 2022 Feb 02, 2023	BUY	$22.15 - $42.11 $59,804 - $113,697	2,700 Added 20.69%	15,750 $598,000
Q3 2022 Nov 04, 2022	SELL	$19.41 - $36.49 $16,653 - $31,308	-858 Reduced 6.17%	13,050 $327,000
Q2 2022 Aug 03, 2022	BUY	$20.71 - $36.5 $17,769 - $31,317	858 Added 6.57%	13,908 $422,000
Q1 2022 May 02, 2022	SELL	$24.12 - $39.6 $581,292 - $954,360	-24,100 Reduced 64.87%	13,050 $427,000
Q4 2021 Feb 23, 2022	BUY	$25.61 - $110.96 $951,411 - $4.12 Million	37,150 New	37,150 $979,000
Q4 2017 Jan 10, 2018	SELL	$22.39 - $33.27 $2,239 - $3,327	-100 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$26.29 - $31.88 $2,629 - $3,188	100	100 $3,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.